Q Pula Trading Management LP Biogen Inc. Transaction History

Q Pula Trading Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $251,866 - $299,515	-1,343 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $412,536 - $519,774	-2,129 Reduced 61.32%	1,343 $283,000
Q4 2021 Feb 08, 2022	SELL	$223.92 - $287.77 $246,535 - $316,834	-1,101 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$282.99 - $369.05 $311,571 - $406,324	1,101 New	1,101 $312,000

1,018

126M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.2B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Q Pula Trading Management LP, based on Form 13F filings with the SEC.

Stay updated on Q Pula Trading Management LP with notifications on news.